ROYCE & ASSOCIATES LP - VIR BIOTECHNOLOGY INC ownership

VIR BIOTECHNOLOGY INC's ticker is VIR and the CUSIP is 92764N102. A total of 229 filers reported holding VIR BIOTECHNOLOGY INC in Q1 2023. The put-call ratio across all filers is 0.67 and the average weighting 0.2%.

Quarter-by-quarter ownership
ROYCE & ASSOCIATES LP ownership history of VIR BIOTECHNOLOGY INC
ValueSharesWeighting
Q3 2023$964,173
-63.5%
102,900
-4.6%
0.01%
-61.5%
Q2 2023$2,644,898
+121.5%
107,823
+110.2%
0.03%
+116.7%
Q1 2023$1,193,914
-17.1%
51,307
-9.8%
0.01%
-20.0%
Q4 2022$1,440,215
+163.8%
56,903
+101.0%
0.02%
+150.0%
Q3 2022$546,00028,3080.01%
Other shareholders
VIR BIOTECHNOLOGY INC shareholders Q1 2023
NameSharesValueWeighting ↓
Bill & Melinda Gates Foundation 1,559,142$36,281,23432.04%
SB INVESTMENT ADVISERS (UK) LTD 18,319,938$426,304,9573.50%
Zebra Capital Management LLC 27,110$6313.15%
Avidity Partners Management LP 1,640,200$38,167,4541.27%
Sofinnova Investments, Inc. 657,559$15,301,3980.98%
DCF Advisers, LLC 62,000$1,442,7400.88%
SECTOR GAMMA AS 145,545$3,386,8320.82%
Temasek Holdings (Private) Ltd 5,814,972$135,314,3980.80%
BRAIDWELL LP 604,036$14,055,9180.46%
SummerHaven Investment Management, LLC 26,045$606,0670.35%
View complete list of VIR BIOTECHNOLOGY INC shareholders